Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Case Comprehensive Cancer Center
University of Washington
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center